MAMEDICA DISPENSARY LIMITED
- Company typePrivate
- Founded2021
- HeadquartersLondon, United Kingdom
- Headcount—
- GTM typeB2C
- OfferingServices
MAMEDICA DISPENSARY LIMITED firmographics
Firmographics- Name
- MAMEDICA DISPENSARY LIMITED
- Legal name
- Mamedica Dispensary Limited
- Website
- http://www.mamedicadispensary.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Ownership category
- akta.pro rank
MAMEDICA DISPENSARY LIMITED industry classification
Industry- Product category
- Medical cannabis dispensary
- NAICS
- Pharmacies and Drug Retailers (456110)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912)
- akta.pro primary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
- akta.pro secondary industries
- Medical Cannabis Dispensaries (CRANAFAB), Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG), Pharmacy & Health Essentials Delivery (CRAFAFAI)
Keywords
Where MAMEDICA DISPENSARY LIMITED is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
MAMEDICA DISPENSARY LIMITED business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Prescription Medication Sales: Revenue generated from dispensing cannabis-based prescription medicines (CBPMs) to patients. Patients pay for their medication before it is prepared. The company offers complimentary postage and packaging for one monthly medication delivery, with a £10 charge for split deliveries. Payment accepted by debit card, credit card, or bank transfer. No refunds are offered once medication has been dispensed due to safety regulations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Prescription-based pricing - individually determined based on medication type and dosage |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels9 records
MAMEDICA DISPENSARY LIMITED product offering
Product offeringCore offering
Mamedica Dispensary Limited is a GPhC-regulated distance-selling pharmacy that dispenses cannabis-based prescription medicines (CBPMs) to UK patients. The pharmacy takes prescriptions (FP10CD) from approved clinics and prescribers, confirms and processes payment, dispenses the medication, and delivers it via secure trackable courier requiring doorstep signature and identification. The core product portfolio covers five medication formats: dried cannabis flower, cannabis oils, vape cartridges, cannabis pastilles, and cannabis capsules.
Product overview
Mamedica Dispensary is a GPhC-regulated distance-selling pharmacy specialising in cannabis-based prescription medicines (CBPMs) for patients across the UK. The dispensary operates as a single, unified pharmacy service — not a modular platform — dispensing medications prescribed by specialist GMC-registered doctors from the companion Mamedica Clinic. The core product portfolio spans five medication formats: Dried Cannabis Flower (for vaporisation), Cannabis Oils (sublingual extracts), Vape Cartridges (inhalation delivery), Cannabis Pastilles (oral edibles), and Cannabis Capsules (oral solid-dose). All products are sourced from approved manufacturers and delivered discretely to patients' doors via secure courier. A patient portal (app.mamedica.com) supports the end-to-end prescription workflow from eligibility checking through order tracking. The dispensary does not have a retail outlet and serves UK residents only.
Differentiator
Problem solved
Functional benefit
Products and services
- Dried Cannabis Flower Dried cannabis flower dispensed as a prescription medicine for vaporisation, providing fast symptom relief through inhalation. Administered using a dry herb vaporiser and supplied to patients with a valid FP10CD prescription.
- Cannabis Oils Cannabis extracts in oil form administered sublingually (under the tongue) using an oral syringe for precise, measured dosing. Many are full-spectrum plant extracts containing THC, CBD, minor cannabinoids, and terpenes.
- Vape Cartridges Discreet, fast-acting vapour delivery using high-quality cannabis extracts in cartridge form, heated via a vaporising device.
- Cannabis Pastilles Flavoured, dose-controlled edible pastilles consumed orally and designed for daily symptom relief.
- Cannabis Capsules Odourless, dose-controlled oral capsules (also referred to as solid fill capsules) taken daily for symptom relief.
- Patient Portal Secure online patient portal (app.mamedica.com) through which patients check eligibility, log in, manage prescriptions, view invoices, and track orders.
Companies that use MAMEDICA DISPENSARY LIMITED
Customer profileSegments6 records
Ideal customer profiles4 records
MAMEDICA DISPENSARY LIMITED technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
MAMEDICA DISPENSARY LIMITED partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights4 records
MAMEDICA DISPENSARY LIMITED competitors and assessment
Company assessmentDirect peers
- Curaleaf Clinic: UK medical cannabis clinic and affiliated pharmacy that assesses patients and dispenses CBPMs via home delivery. Directly comparable as a UK CBPM prescriber and dispenser operating under similar GPhC and GMC frameworks.
- Sapphire Medical Clinic: UK medical cannabis clinic run by GMC-registered specialists, prescribing CBPMs for chronic pain, psychiatry, neurology and oncology. Comparable as a specialist-led CBPM prescriber operating in the same condition areas as Mamedica.
- Lyphe Clinic: UK medical cannabis clinic and dispensary (formerly The Cannabis Clinic) providing specialist consultations and dispensing CBPMs via home delivery. Operates a similar clinic-to-pharmacy referral model for UK patients.
- Zerenia Clinic: UK medical cannabis clinic operated by a specialist team prescribing CBPMs for chronic pain, mental health and neurological conditions. Direct competitor for UK CBPM consultations and dispensing.
- Integro Medical Clinics: UK medical cannabis clinic offering specialist consultations and prescriptions for CBPMs across pain, psychiatry and neurology. Comparable specialist-led prescriber competing for the same patient pool.
- Cannabis Access Clinics: UK network of specialist doctors prescribing medical cannabis for chronic pain and other eligible conditions. Direct competitor in the UK CBPM prescribing space feeding into dispensing.
- CB1 Medical: UK medical cannabis clinic with GMC specialist doctors prescribing CBPMs and dispensing via partner pharmacies. Comparable integrated clinic-and-dispensary CBPM provider in the UK.
- Alternaleaf: UK-based medical cannabis clinic that assesses patients online and issues CBPM prescriptions fulfilled via partner pharmacies. Comparable online consultation and prescription delivery model for UK patients.
Others
- Cantourage: UK-headquartered cannabis pharmaceutical company supplying imported CBPMs and operating a distribution platform for UK medical cannabis dispensing. Comparable as a UK CBPM supply-chain participant, not a direct clinic competitor.
- Drug Science (Project Twenty21): UK medical cannabis observational registry and patient access programme (Project Twenty21) that connects patients to CBPM-prescribing clinics and pharmacies. Comparable ecosystem participant shaping UK CBPM demand.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks6 records
Key highlights7 records
Customer concentration
MAMEDICA DISPENSARY LIMITED social profiles
Digital presenceMAMEDICA DISPENSARY LIMITED compliance and trust
Trust signalCompliance6 records
MAMEDICA DISPENSARY LIMITED financial estimates
Financial estimateRevenue estimate
Valuation estimate
MAMEDICA DISPENSARY LIMITED leadership team
Management profileNumber of profiles
Profiles1 record
MAMEDICA DISPENSARY LIMITED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MAMEDICA DISPENSARY LIMITED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MAMEDICA DISPENSARY LIMITED
What does MAMEDICA DISPENSARY LIMITED do?
Mamedica Dispensary Limited is a GPhC-regulated distance-selling pharmacy that dispenses cannabis-based prescription medicines (CBPMs) to UK patients. The pharmacy takes prescriptions (FP10CD) from approved clinics and prescribers, confirms and processes payment, dispenses the medication, and delivers it via secure trackable courier requiring doorstep signature and identification. The core product portfolio covers five medication formats: dried cannabis flower, cannabis oils, vape cartridges, cannabis pastilles, and cannabis capsules.
Is MAMEDICA DISPENSARY LIMITED a public or private company?
MAMEDICA DISPENSARY LIMITED is a private company. It is classified as unknown and is currently operating.
When was MAMEDICA DISPENSARY LIMITED founded?
MAMEDICA DISPENSARY LIMITED was founded in 2021.
Where is MAMEDICA DISPENSARY LIMITED based?
MAMEDICA DISPENSARY LIMITED is headquartered in London, United Kingdom, in the Europe region.
How does MAMEDICA DISPENSARY LIMITED make money?
One revenue line is on record: prescription Medication Sales.
Who are MAMEDICA DISPENSARY LIMITED's main competitors?
Direct peers on record are Curaleaf Clinic, Sapphire Medical Clinic, Lyphe Clinic, Zerenia Clinic, Integro Medical Clinics, Cannabis Access Clinics, CB1 Medical and Alternaleaf. Others are Cantourage and Drug Science (Project Twenty21).
Does MAMEDICA DISPENSARY LIMITED have an API?
No public API is recorded for MAMEDICA DISPENSARY LIMITED.
What industry is MAMEDICA DISPENSARY LIMITED in?
MAMEDICA DISPENSARY LIMITED's product category is Medical cannabis dispensary. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 456110 and its SIC code is 5912.